Boothbay Fund Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
+128,845
| New | +$1.21M | 0.02% | 474 |
|
|
2023
Q4 | – | Sell |
-76,909
| Closed | -$1.12M | – | 1774 |
|
|
2023
Q3 | $1.12M | Buy |
76,909
+404
| +0.5% | +$5.87K | 0.03% | 587 |
|
|
2023
Q2 | $1.6M | Buy |
+76,505
| New | +$1.6M | 0.04% | 511 |
|
|
2021
Q1 | – | Sell |
-15,324
| Closed | -$341K | – | 1544 |
|
|
2020
Q4 | $341K | Buy |
+15,324
| New | +$341K | 0.01% | 755 |
|
|
2018
Q4 | – | Sell |
-10,000
| Closed | -$81K | – | 778 |
|
|
2018
Q3 | $81K | Buy |
+10,000
| New | +$81K | 0.01% | 604 |
|
|
2017
Q3 | – | Sell |
-15,689
| Closed | -$219K | – | 677 |
|
|
2017
Q2 | $219K | Buy |
+15,689
| New | +$219K | 0.05% | 448 |
|